These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 37924451)

  • 1. Ghrelin hormone a new molecular modulator between obesity and glomerular damage.
    Ibrahim M; Khalife L; Abdel-Latif R; Faour WH
    Mol Biol Rep; 2023 Dec; 50(12):10525-10533. PubMed ID: 37924451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ghrelin modulates intracellular signalling pathways that are critical for podocyte survival.
    El Zein N; Abdallah MS; Daher CF; Mroueh M; Stephan J; Bahous SA; Eid A; Faour WH
    Cell Biochem Funct; 2019 Jun; 37(4):245-255. PubMed ID: 31017709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome.
    Thethi T; Kamiyama M; Kobori H
    Curr Hypertens Rep; 2012 Apr; 14(2):160-9. PubMed ID: 22302531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of adipose tissue in chronic kidney disease development (Review).
    Miricescu D; Balan DG; Tulin A; Stiru O; Vacaroiu IA; Mihai DA; Popa CC; Enyedi M; Nedelea AS; Nica AE; Stefani C
    Exp Ther Med; 2021 May; 21(5):539. PubMed ID: 33815612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney Damage Caused by Obesity and Its Feasible Treatment Drugs.
    Wang M; Wang Z; Chen Y; Dong Y
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.
    D'Agati VD; Chagnac A; de Vries AP; Levi M; Porrini E; Herman-Edelstein M; Praga M
    Nat Rev Nephrol; 2016 Aug; 12(8):453-71. PubMed ID: 27263398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases.
    Rüster C; Wolf G
    Semin Nephrol; 2013 Jan; 33(1):44-53. PubMed ID: 23374893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinuria: detection and role in native renal disease progression.
    Gorriz JL; Martinez-Castelao A
    Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin Levels and Decreased Kidney Function in Patients with Early Stages of Chronic Kidney Disease Against the Background of Obesity.
    Gubina NV; Kupnovytska IH; Mishchuk VH; Markiv HD
    J Med Life; 2020; 13(4):530-535. PubMed ID: 33456602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal consequences of obesity.
    Naumnik B; Myśliwiec M
    Med Sci Monit; 2010 Aug; 16(8):RA163-70. PubMed ID: 20671624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of Glomerular Hyperfiltration: The Role of Physical Forces in the Pathogenesis of Chronic Kidney Disease in Diabetes and Obesity.
    Chagnac A; Zingerman B; Rozen-Zvi B; Herman-Edelstein M
    Nephron; 2019; 143(1):38-42. PubMed ID: 30947190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and chronic kidney disease.
    Jiang Z; Wang Y; Zhao X; Cui H; Han M; Ren X; Gang X; Wang G
    Am J Physiol Endocrinol Metab; 2023 Jan; 324(1):E24-E41. PubMed ID: 36383637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocytopathy in Obesity: Challenges of Living Large.
    Giannini G; Kopp JB; Rosenberg AZ
    Semin Nephrol; 2021 Jul; 41(4):307-317. PubMed ID: 34715961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of (pro)renin receptor in the glomerular filtration barrier.
    Ichihara A; Sakoda M; Kurauchi-Mito A; Kaneshiro Y; Itoh H
    J Mol Med (Berl); 2008 Jun; 86(6):629-35. PubMed ID: 18335185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fatty Kidney and Beyond: A Silent Epidemic.
    Hti Lar Seng NS; Lohana P; Chandra S; Jim B
    Am J Med; 2023 Oct; 136(10):965-974. PubMed ID: 37451390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric endocrine aspects of ghrelin.
    Lim CT; Korbonits M
    Pediatr Endocrinol Rev; 2012 Mar; 9(3):628-38. PubMed ID: 22523830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic role of Renin-Angiotensin System blockers in obesity- related renal disorders.
    Santos SH; Simões e Silva AC
    Curr Clin Pharmacol; 2014 Feb; 9(1):2-9. PubMed ID: 23270435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of hypertension and kidney disease in obesity.
    Hall JE; Brands MW; Henegar JR
    Ann N Y Acad Sci; 1999 Nov; 892():91-107. PubMed ID: 10842655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal disease in obesity: the need for greater attention.
    Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A
    J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Renal Pathology of Obesity: Structure-Function Correlations.
    Tsuboi N; Okabayashi Y
    Semin Nephrol; 2021 Jul; 41(4):296-306. PubMed ID: 34715960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.